Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1157 | 1066 | 1178 | 1531 | 1508 | 2574 |
Fund Return | 15.69% | 6.63% | 17.77% | 15.26% | 8.56% | 9.92% |
Place in category | 285 | 365 | 399 | 645 | 392 | 260 |
% in Category | 13 | 18 | 21 | 37 | 28 | 30 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Swedbank Robur Technology | 155.12B | 13.73 | 22.42 | 25.11 | ||
Swedbank Robur IP Aktiefond | 70.23B | 10.71 | 19.37 | 18.13 | ||
SE0013109519 | 55.81B | 19.51 | 24.39 | 17.64 | ||
Swedbank Robur Allemansfond Komple | 97.61B | 22.01 | 16.13 | 12.64 | ||
Swedbank Robur Aktiefond Pension | 83.09B | 14.38 | 16.22 | 12.15 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Handelsbanken Europafond Index | 20.24B | 11.56 | 12.59 | 9.59 | ||
Handelsbanken European Index utd | 20.24B | 11.56 | 12.59 | 9.11 | ||
SPP Aktiefond Europa | 17.07B | 11.53 | 13.07 | 9.68 | ||
Lansforsakringar Europa Indexnara | 10.6B | 12.04 | 12.97 | 9.53 | ||
FI4000048988 | 10.17B | 9.87 | 11.48 | 9.88 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Nestle | CH0038863350 | 3.63 | 92.08 | -2.02% | |
ASML Holding | NL0010273215 | 3.02 | 833.70 | -0.13% | |
Novo Nordisk A/S Class B | DK0060534915 | 2.67 | - | - | |
Roche Holding Participation | CH0012032048 | 2.64 | 218.80 | -1.53% | |
AstraZeneca | GB0009895292 | 2.38 | 12,026.0 | +5.94% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review